A study has revealed that the deficiency of steroid hormones called androgens, such as testosterone, may be behind cardiovascular disease.
Published in the Journal of Andrology, a report on the study underscores the fact that a number of studies have linked androgen deficiency to an increased mortality in men.
Anabolic Steroids
Anabolic steroids can produce power- packed, adrenaline - pumping performances but they also reflect a saga of condemnation and shame.
Advertisement
Testosterone (T) is an anabolic hormone with a wide range of beneficial effects on men's health.
However, according to Boston University School of Medicine (BUSM) researchers, the therapeutic role of T in men's health remains a hotly debated issue for a number of reasons, including the purported risk of prostate cancer.
![Puzzle of Prostate Cancer Resistance to Androgen-Deprivation Therapy Solved]( "Puzzle of Prostate Cancer Resistance to Androgen-Deprivation Therapy Solved")
A collaborative study has uncovered what may be helpful in discerning how prostate tumours eventually become resistant to androgen-deprivation therapy - the suppression of circulating
Working in collaboration with researchers from Lahey Clinic Northshore, Peabody, Massachusetts, they evaluated several relevant articles pertinent to androgen deficiency and vascular disease, and determined that a relationship did exist between androgen deficiency and CVD.
"In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men. It should be emphasized, however, that androgen replacement therapy should be done with very thorough and careful monitoring for prostate diseases," said lead author Dr. Abdulmaged M. Traish, a professor of biochemistry and urology as well as the director of Laboratories for Sexual Medicine, Institute for Sexual Medicine at BUSM.
To further elucidate the role of androgen deficiency in vascular disease, the researchers recommend large, long-term, double-blind, randomised, placebo-controlled clinical trials be carried out.
"Although challenges might lie ahead regarding how data from such clinical trials are to be properly interpreted and whether long-term safety can be established with T supplementation, these findings warrant definite investigation into the beneficial role that androgens might have in preventing cardiovascular risk in androgen-deficient men," added Traish.
Source: ANI
TAN
Puzzle of Prostate Cancer Resistance to Androgen-Deprivation Therapy Solved
A collaborative study has uncovered what may be helpful in discerning how prostate tumours eventually become resistant to androgen-deprivation therapy - the suppression of circulating
Advertisement
Working in collaboration with researchers from Lahey Clinic Northshore, Peabody, Massachusetts, they evaluated several relevant articles pertinent to androgen deficiency and vascular disease, and determined that a relationship did exist between androgen deficiency and CVD.
"In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men. It should be emphasized, however, that androgen replacement therapy should be done with very thorough and careful monitoring for prostate diseases," said lead author Dr. Abdulmaged M. Traish, a professor of biochemistry and urology as well as the director of Laboratories for Sexual Medicine, Institute for Sexual Medicine at BUSM.
To further elucidate the role of androgen deficiency in vascular disease, the researchers recommend large, long-term, double-blind, randomised, placebo-controlled clinical trials be carried out.
"Although challenges might lie ahead regarding how data from such clinical trials are to be properly interpreted and whether long-term safety can be established with T supplementation, these findings warrant definite investigation into the beneficial role that androgens might have in preventing cardiovascular risk in androgen-deficient men," added Traish.
Source: ANI
TAN
Androgen Deprivation Therapy may Encourage Spread of Prostate Cancer.
Androgen deprivation therapy a popular prostate cancer treatment may encourage prostate cancer cells
Advertisement
 Androgen Deprivation Therapy Increases Risk of Heart Disease DeathTreating prostate cancer through androgen deprivation therapy has been found to be associated with an increased risk of death from heart disease. | Advertisement
|
Advertisement
Recommended Reading
Latest Heart Disease News
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.
Researchers analyzed the link between muscle strength and the risk of developing heart failure in patients who had a heart attack without prior history of complications.
Heart health scores for gay and bisexual men were 2.72 and 0.83 points superior, respectively, compared to heterosexual men.
Research suggests that individuals with robust leg muscles have a reduced risk of developing heart failure following a heart attack.
Is marijuana bad for your heart? Yes, marijuana use may put you at a higher risk of developing peripheral artery disease (PAD). Check out the impact of marijuana use on health.